Risk of over- and under- treatment with levothyroxine in primary care in Copenhagen, Denmark.

Jeppe Lerche la CourBjarke Røssner MediciMia Klinten GrandDagny Ros NicolaisdottirBent LindJens FaberChristen Lykkegaard AndersenBirte Nygaard

Published in: European journal of endocrinology (2021)

Although a still decreasing threshold for initiating L-T4 therapy is known, the risk of overtreatment (and undertreatment) was low and lessened in the period 2001-2012 among Danish primary care patients. Nevertheless, as many as 18% were started on L-T4 with normal TSH levels.

Keyphrases

primary care
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
general practice